Showing studies matching your search5 results shown

Studies (5 shown)

NCT05999084RECRUITING

Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry

Sponsor · Emory UniversityCondition · Alzheimer DiseaseIntervention · Anti-amyloid Monoclonal Antibodies (mAbs), Standard of CareUpdated Mar 2026
NCT06602258PHASE2ACTIVE_NOT_RECRUITING

A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease

Sponsor · Eisai Inc.Condition · Alzheimer's DiseaseIntervention · E2814, LecanemabUpdated Feb 2026
NCT05469009EARLY_PHASE1ACTIVE_NOT_RECRUITING

Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for Mild Cognitive Impairment or Mild Alzheimer's Disease Undergoing Standard of Care Monoclonal Antibody (mAb) Therapy

Sponsor · Ali RezaiCondition · Mild Cognitive Impairment, Alzheimer Disease 1Intervention · Aducanumab, Exablate Model 4000 Type 2Updated Jan 2026
NCT07034222PHASE4ACTIVE_NOT_RECRUITING

12-Month Real-World Safety & Efficacy of Lecanemab in Early Alzheimer's Disease

Sponsor · Ruijin HospitalCondition · Alzheimer's Disease(AD)Intervention · Administer Leqemi 10 mg/kg, every two weeks.Updated Jun 2025
NCT06023446ENROLLING_BY_INVITATION

Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?

Sponsor · University of California, DavisCondition · Alzheimer Disease, Mild Cognitive ImpairmentIntervention · Optical Coherence TomographyUpdated Dec 2025
Showing top 5 results. See all 5 results on CT.gov →